# MK-2206 in Recurrent Nasopharyngeal Carcinoma

> **NCT01370070** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 12 (actual)

## Conditions studied

- Recurrent Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** MK-2206

## Key facts

- **NCT ID:** NCT01370070
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370070, "MK-2206 in Recurrent Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01370070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*